Diphenylcyclopropenone in Patients with Alopecia Areata: A Critically Appraised Topic
October 2015
in “
British Journal of Dermatology
”
TLDR Diphenylcyclopropenone's effectiveness and safety for alopecia areata are unclear.
The document concluded that there was very low quality evidence supporting the effectiveness and safety of diphenylcyclopropenone in treating extensive resistant alopecia areata. It emphasized the need for well-designed and well-conducted randomized controlled trials with comprehensive reporting and high-quality methodological descriptions to better assess the treatment's efficacy and safety.